Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge zum Wirkstoff Tiotropiumbromid, Darreichungsform Inhalationslösung, ATC R03BB04

Health · Germany government procurement

GlobalGov surfaces government procurement from around the world, including the markets your competitors overlook.

March 31, 2027
Response Due
Active
Status

Opportunity Overview

Germany – Pharmaceutical products – Open house drug discount agreements for the active ingredient tiotropium bromide, dosage form inhalation solution, ATC R03BB04

This Germany Pharmaceuticals opportunity is one most of your competitors will never see.

How to bid: GlobalGov tracks this tender; it does not accept bids. Submit your response through the issuing agency’s official notice.

Your competitors are watching the same crowded contracts everyone else is. Track this opportunity and every one like it worldwide, set deadline alerts, and win where they aren’t. Free for 14 days, no card.

Start a free GlobalGov account

Solicitation Details

Issuing agencyHealth
CountryGermany
CategoryPharmaceuticals
PublishedApril 11, 2025
Procurement stageActive solicitation
Response dueMarch 31, 2027
StatusOpen — accepting responses
Original languageGerman — members read it in their own language
Official sourceView original notice
Last verifiedOctober 11, 2026

Source: Tenders Electronic Daily (TED), © European Union. Notice content reused under Commission Decision 2011/833/EU; editorial content licensed CC BY 4.0. GlobalGov is not affiliated with the European Union.

Related Opportunities in Germany

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Alfacalcidol (ATC-Code nach WHO: A11CC03) in der Darreichungsform Weichkapseln
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge zum Wirkstoff Denosumab, ATC M05BX04
Germany – Pharmaceutical products – Arzneimittel mit dem Wirkstoff Axitinib (ATC: L01EK01)
Germany – Pharmaceutical products – Arzneimittel mit dem Wirkstoff Pyridostigmin (ATC: N07AA02)
Germany – Pharmaceutical products – Arzneimittel mit dem Wirkstoff Zolmitriptan (ATC: N02CC03 - für die nasale Applikation)
Germany – Pharmaceutical products – Arzneimittel-Rabattverträge ab 01.09.2025 zu diversen Wirkstoffen im Rahmen eines Open-House-Verfahrens
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Anakinra, ATC L04AC03
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Amifampridin, ATC N07XX05

See every Germany Pharmaceuticals opportunity your competition is missing. Free for 14 days.

Get real-time alerts, competitive intelligence, and deadline tracking for this and every market worldwide.

Start Free Trial — No Card Required

Free 14-day trial · no card required

See who is already competing here →

Get a free Germany Pharmaceuticals intelligence report in your inbox

A personalized report on Germany Pharmaceuticals opportunities, emailed in 5-10 minutes. One per month, no account needed.